Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

137.58 +3.77 (+2.82%)
Streaming Delayed Price Updated: 12:23 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
TransMedics Group Inc (TMDX) Fits the Minervini Trend Template with Strong-Growth Momentum ↗
Via Chartmill
TransMedics Group Inc (NASDAQ:TMDX): A GARP Investment Case Study ↗
Via Chartmill
News headline image
Stocks to Love in 2026 ↗
Are you looking for investment opportunities in 2026? 
Via The Motley Fool
Topics ETFs Initial Public Offering
TransMedics Group Inc. (NASDAQ:TMDX) Combines High-Growth Momentum with Bullish Technical Setup ↗
Via Chartmill
News headline image
6 Multibagger Stocks to Buy Before They Explode in 2026 ↗
With great returns comes added volatility. 
Via The Motley Fool
News headline image
Here Are My Top 2 No-Brainer Growth Stocks to Buy Now ↗
These businesses are innovators in their respective industries. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
A Peek at TransMedics Gr's Future Earnings ↗
 
Via Benzinga
News headline image
Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety
As the final trading days of 2025 approach, the Nasdaq has reached a staggering milestone that has both bulls and bears on edge. According to the latest settlement data released on December 15, 2025,... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
TransMedics Group Inc (NASDAQ:TMDX) Emerges as a Prime GARP Candidate ↗
TransMedics (TMDX) exemplifies Growth at a Reasonable Price (GARP) with strong revenue growth, solid industry valuation, and improving profitability in medical tech. 
Via Chartmill
News headline image
2 Under-the-Radar Stocks That Have Soared This Year ↗
These companies are worth your attention. 
Via The Motley Fool
News headline image
TransMedics Director Sells 4,142 Shares as Wall Street Maintains Buy Ratings: Is the Stock Still a Buy? ↗
A TransMedics executive trimmed his position by $540,300. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Top Stocks to Buy in December ↗
These stocks deserve a spot on investors' shopping lists this holiday season. 
Via The Motley Fool
News headline image
1 Growth Stock I'm Thankful for -- and the Unstoppable Stock I'm Buying Using the Lessons It Taught Me ↗
Without learning from my worst investing decision, I would have missed out on many of my best long-term investments. 
Via The Motley Fool
News headline image
Dycom Industries, BellRing Brands, Lumentum And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
4 Growth Stocks to Buy After the Recent Crash ↗
All four trade at reasonable valuations. 
Via The Motley Fool
News headline image
Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks ↗
Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten. 
Via Benzinga
News headline image
2 Strong Healthcare Stock Picks for Growth Investors ↗
If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space. 
Via The Motley Fool
News headline image
TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Stock for GARP Investors ↗
TransMedics Group (TMDX) is a GARP stock with strong revenue & EPS growth, reasonable valuation vs. peers, and a solid financial position. 
Via Chartmill
News headline image
TransMedics Group Inc (NASDAQ:TMDX) Passes Rigorous Growth Stock Screen ↗
Discover how TransMedics Group (TMDX) exemplifies a powerful growth investing strategy with explosive sales, earnings growth, and soaring profitability. 
Via Chartmill
News headline image
Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ ↗
TransMedics shares fell 9% in after-hours trading after its third-quarter results showed strong year-over-year growth but a sequential slowdown and margin pressure. 
Via Stocktwits
News headline image
TransMedics (TMDX) Q3 2025 Earnings Transcript ↗
TransMedics (TMDX) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
TransMedics Group Inc (NASDAQ:TMDX) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗
TransMedics (TMDX) Q3 2025 results show a mixed picture: EPS of $0.66 beat estimates by 84.6%, but revenue of $143.82M slightly missed forecasts. 
Via Chartmill
News headline image
4 Stocks to Load Up on Before Earnings ↗
It might be worth buying these companies before the market notices they are undervalued. 
Via The Motley Fool
News headline image
This CME Group Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Is TransMedics Group Inc Gaining or Losing Market Support? ↗
 
Via Benzinga
News headline image
4 Analysts Have This To Say About TransMedics Group ↗
 
Via Benzinga
News headline image
TransMedics Group Inc (NASDAQ:TMDX): A GARP Investment with Strong Growth and Fair Valuation ↗
TransMedics (TMDX) is a top GARP stock with explosive revenue & earnings growth, strong profitability, and a reasonable valuation relative to its industry peers. 
Via Chartmill
News headline image
2 Outstanding Healthcare Stocks to Buy and Hold for a Decade ↗
These stocks are crushing the market this year, and there is likely plenty of upside ahead. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.